Fred Hutch and the Seattle Cancer Care Alliance awarded Bank of America grant for COVID-19 relief efforts

Seattle Cancer Care Alliance

Newswise — SEATTLE — May 11, 2020 — Fred Hutchinson Cancer Research Center and its clinical-care partner, Seattle Cancer Care Alliance, announced today the organizations are receiving a $500,000 grant from Bank of America for COVID-19 relief.

A portion of the funds will support critical parts of Fred Hutch’s COVID-19 response by accelerating efforts for the development and evaluation of rapid testing and point-of-care tests, to help get both the Fred Hutch and greater Seattle community, back to work safely. Part of the grant will also fund the purchase of personal protective equipment and UV sterilizer for SCCA staff to safely provide the best care for cancer patients during the pandemic.

“We’re honored to partner with Bank of America to accelerate our mission and drive our renowned scientists to better understand and eventually find a cure for COVID,” said Dr. Thomas Lynch, president and director of Fred Hutch and holder of the Raisbeck Endowed Chair. “This underscores the power and importance of investing in Fred Hutch’s life-saving research.”

Since the start of the COVID-19 outbreak, Fred Hutch researchers have played an important part of a collective, international scientific response — tracking the virus's spread, developing diagnostic tests, designing vaccine trials and working to prevent future outbreaks.

As one of the first cancer centers in the country to confront the outbreak, SCCA continues to provide world-class cancer treatment while rapidly adjusting its approach to care to include testing patients and staff for the virus, fast-tracking telehealth offerings for appointments when medically appropriate and actively working to safely resume patient care across its clinics.

“Despite the challenges COVID-19 presents, I’m proud of the SCCA team’s resilience and selflessness in caring for our patient community,” said Dr. Nancy Davidson, president and executive director of SCCA and senior vice president and director of Fred Hutch’s Clinical Research Division. “We applaud Bank of America for doing its part to keep our providers and patients safe.”

The grant is part of Bank of America’s $100 million national effort to support local communities in need. Since announcing their efforts in March, Bank of America has awarded grants to 13 Puget Sound area organizations, addressing immediate needs such as emergency support services, affordable housing, food insecurity and childcare for frontline workers.

Bank of America awarded the grant to Fred Hutch based on the organization’s collective expertise in global health threats, making them ideal partners in the fight against COVID-19.

“This unprecedented health and humanitarian crisis has placed enormous challenges on our healthcare community,” said Kerri Schroeder, Seattle Market President for Bank of America. “We are committed to helping by delivering financial resources that support Fred Hutch’s efforts to deploy more testing and ensuring our healthcare workers are safe so they can continue to innovate and focus on serving those who need help the most.”

For more information on Fred Hutch’s response to the COVID-19 pandemic, visit Fred Hutch’s Coronavirus Overview Page. To find out how SCCA is responding to the pandemic, visit SCCA’s COVID-19 Patient Page.

                                                                                                  ##

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.

Seattle Cancer Care Alliance (SCCA) brings together the leading research teams and cancer specialists from Fred Hutch, Seattle Children’s and UW Medicine — one extraordinary group whose sole purpose is the pursuit of better, longer, richer lives for our patients. Based in Seattle’s South Lake Union neighborhood, SCCA has eight clinical care sites, including a medical oncology clinic at EvergreenHealth in Kirkland, Washington; medical and radiation oncology clinics at UW Medical Center – Montlake and UW Medical Center – Northwest in Seattle, Washington, medical and radiation oncology services at SCCA Peninsula and medical oncology services at SCCA Issaquah, as well as Network affiliations with hospitals in five states.



Filters close

Showing results

110 of 5848
Newswise:Video Embedded virtual-event-for-june-17-11am-edt-covid-19-vaccines-and-male-fertility
VIDEO
Released: 18-Jun-2021 8:55 AM EDT
VIDEO AND TRANSCRIPT AVAILABLE: Vaccines and Male Fertility Event for June 17, 2021
Newswise

This upcoming JAMA-published study examined whether the COVID-19 vaccine impacts male fertility.

access_time Embargo lifts in 2 days
Embargo will expire: 22-Jun-2021 11:00 AM EDT Released to reporters: 18-Jun-2021 8:30 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Jun-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Jun-2021 7:05 AM EDT
Teamwork saves lives: COVID-19 hospital network shares key findings to improve care
Michigan Medicine - University of Michigan

Data sharing among 40 Michigan hospitals about the care and outcomes for thousands of inpatients with COVID-19 has led to reduced variation and findings that could inform care anywhere, including approaches for preventing blood clots and reducing overuse of antibiotics, as well as a risk prediction tool.

Released: 18-Jun-2021 7:05 AM EDT
One-third of older Americans delayed health care over COVID concerns
Michigan Medicine - University of Michigan

Nearly one in three Americans between the ages of 50 and 80 put off an in-person appointment for medical care in 2020 because they were worried about exposure to the novel coronavirus, new national poll data show.

Released: 17-Jun-2021 4:15 PM EDT
UNC Researchers Lead Study of Diabetes Treatment of COVID-19 Patients
University of North Carolina School of Medicine

Diabetes is one of the comorbidities most strongly associated with severe COVID-19 in the US, and data from early in the pandemic suggested individuals with type 2 diabetes faced twice the risk of death from COVID-19 and a greater risk of requiring hospitalization and intensive care. A new study shows best treatment options.

Released: 17-Jun-2021 4:10 PM EDT
Vaccination, Previous Infection, Protect Against COVID-19 gamma/P.1 Variant in Animal Model
University of Wisconsin-Madison

In a new study using variant virus recovered from one of the original travelers, researchers in the U.S. and Japan have found that vaccination with an mRNA vaccine induces antibody responses that would protect humans from infection with the gamma/P.1 variant.

Released: 17-Jun-2021 1:30 PM EDT
Hackensack Meridian Doctors, Student Help Establish Way to Prioritize Surgeries During COVID-19 lockdown
Hackensack Meridian Health

The MeNTS method of prioritizing surgeries during the height of pandemic, developed by University of Chicago, helped procedures continue during time of need

Released: 17-Jun-2021 12:55 PM EDT
‘Nanodecoy’ Therapy Binds and Neutralizes SARS-CoV-2 Virus
North Carolina State University

Nanodecoys made from human lung spheroid cells (LSCs) can bind to and neutralize SARS-CoV-2, promoting viral clearance and reducing lung injury in a macaque model of COVID-19.

access_time Embargo lifts in 2 days
Embargo will expire: 21-Jun-2021 11:00 AM EDT Released to reporters: 17-Jun-2021 12:10 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 21-Jun-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Blood Cancer Patients with COVID-19 Fare Better with Convalescent Plasma
Released: 17-Jun-2021 11:55 AM EDT
Blood Cancer Patients with COVID-19 Fare Better with Convalescent Plasma
Washington University in St. Louis

A large, retrospective, multicenter study involving Washington University School of Medicine in St. Louis indicates that convalescent plasma from recovered COVID-19 patients can dramatically improve likelihood of survival among blood cancer patients hospitalized with the virus. The therapy involves transfusing plasma — the pale yellow liquid in blood that is rich in antibodies — from people who have recovered from COVID-19 into patients who have leukemia, lymphoma or other blood cancers and are hospitalized with the viral infection.


Showing results

110 of 5848

close
11.37029